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Abstract
Cornelia de Lange syndrome (CdLS), a disorder caused by mutations in cohesion proteins, is characterized by multisystem
developmental abnormalities. PDS5, a cohesion protein, is important for proper chromosome segregation in lower
organisms and has two homologues in vertebrates (PDS5A and PDS5B). Pds5B mutant mice have developmental
abnormalities resembling CdLS; however the role of Pds5A in mammals and the association of PDS5 proteins with CdLS are
unknown. To delineate genetic interactions between Pds5A and Pds5B and explore mechanisms underlying phenotypic
variability, we generated Pds5A-deficient mice. Curiously, these mice exhibit multiple abnormalities that were previously
observed in Pds5B-deficient mice, including cleft palate, skeletal patterning defects, growth retardation, congenital heart
defects and delayed migration of enteric neuron precursors. They also frequently display renal agenesis, an abnormality not
observed in Pds5B
2/2 mice. While Pds5A
2/2 and Pds5B
2/2 mice die at birth, embryos harboring 3 mutant Pds5 alleles die
between E11.5 and E12.5 most likely of heart failure, indicating that total Pds5 gene dosage is critical for normal
development. In addition, characterization of these compound homozygous-heterozygous mice revealed a severe
abnormality in lens formation that does not occur in either Pds5A
2/2 or Pds5B
2/2 mice. We further identified a functional
missense mutation (R1292Q) in the PDS5B DNA-binding domain in a familial case of CdLS, in which affected individuals also
develop megacolon. This study shows that PDS5A and PDS5B functions other than those involving chromosomal dynamics
are important for normal development, highlights the sensitivity of key developmental processes on PDS5 signaling, and
provides mechanistic insights into how PDS5 mutations may lead to CdLS.
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Introduction
Cornelia de Lange syndrome (CdLS; OMIM #122470) is a rare
developmental disorder (,1:10,000) characterized by mental
retardation, myopia, growth retardation, congenital heart defects,
intestinal anomalies, facial dysmorphisms including cleft palate and
appendicular skeletal malformations [1]. A breakthrough in the
understanding of CdLSoccurred when mutations inthe NIPBL gene
were identified in ,50% of CdLS patients [2,3]. NIPBL protein is
required for cohesin, a protein complex that mediates sister
chromatid cohesion, to bind to chromosomes. More recently,
mutations in SMC1A and SMC3, core components of cohesin, have
been identified in CdLS patients [4], indicating that cohesin
dysfunction is the basis of the anomalies associated with CdLS. In
addition, mutations in ESCO2, a protein acetyltransferase required
for sister chromatid cohesion, have been identified in Robert’s
syndrome (RBS; OMIM # 268300), a developmental disorder with
similarities to CdLS [5,6]. Most CdLS cases are sporadic (.99%),
but some show an autosomal dominant [2,7] or X-linked recessive
pattern of inheritance with variable expressivity or incomplete
penetrance [8]. Interestingly, the abnormalities of affected individ-
uals that share the same mutation even within families can vary
widely [8–11]. The mechanistic basis of variability in phenotypic
expressivity and penetrance in CdLS are unknown but are thought
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influences [12].
Cohesin is a highly conserved multi-protein complex required
for sister chromatid cohesion, a process that ensures accurate
chromosomal segregation during cell division. The cohesin
complex consists of the core components, SMC1, SMC3,
SCC1(RAD21) and SCC3 (SA), and is regulated by the associated
factors, PDS5 (PDS5A and PDS5B in mammals), WAPL, SCC2
(NIPBL), SCC4 (MAU-2), ECO1 (ESCO1 and ESCO2 in
mammals) and Separase [13–17]. In addition to chromosomal
dynamics, cohesin and its regulatory factors play important roles
in development by regulating cell movement and axonal
outgrowth in C. elegans [18,19], transcriptional regulation of
neurodevelopmental regulators in Zebrafish [20], and control of
long-range gene expression in Drosophila [21]. Most recently, the
non-mitotic functions of cohesin and cohesin-associated proteins
have been highlighted by their high expression in post-mitotic
neurons in adult mice [22,23], the neuronal deficits in Pds5B-
deficient mice [22], and the discovery that Drosophila mutants in
SMC1, RAD21, and SA have defects in axonal pruning and
dendritic targeting [24,25]. These studies, coupled with the
identification of causative mutations in cohesin components in
human developmental syndromes, promise to shed new light on
the non-canonical functions of cohesin and cohesin-associated
proteins during development.
While early work in Drosophila indicated that Nipped-B (NIPBL,
SCC2) is important for regulating long-range gene expression of
the cut locus [26], the role of cohesin in transcription has been
difficult to decipher. A recent genome-wide study in Drosophila
showed that Nipped-B and cohesin bind to the transcribed and
regulatory regions of many active developmental genes [27],
providing further evidence for cohesin-mediated transcriptional
regulation. ChIP-on-Chip analysis of cohesin binding sites across
the human genome and 3% of the mouse genome revealed that
cohesin is bound to chromatin at ,9,000 sites and, that most of
these sites overlap with binding sites for the chromatin insulator
protein CTCF [23,28]. The co-localization of cohesin and CTCF
suggests that a possible molecular mechanism underlying devel-
opmental disorders caused by cohesin component mutations is the
aberrant regulation of gene expression. The molecular features of
CTCF (a transcriptional insulator) and cohesin, which topologi-
cally encircles chromosomes [29], suggest that together they may
regulate gene expression through control of global nuclear
dynamics, such as interchromosomal or intrachromosomal
looping. The contribution of cohesin to CTCF-mediated insulator
activity [23] could account for the variability in phenotypic
expressivity and penetrance observed in CdLS.
The molecular functions of PDS5A and PDS5B in mammals
are largely unknown, but their homologues in lower organisms are
required for sister chromatid cohesion and interact genetically
and/or physically with cohesin core components and its accessory
factors [30]. In fungi, PDS5 antagonizes the establishment of
cohesion until counteracted by ECO1 [31] and is acetylated by
ECO1 in vitro [32]. PDS5A and PDS5B are very similar except for
the addition of two AT-hook motifs at the carboxy terminus of
PDS5B. PDS5A and PDS5B both interact with WAPL, a cohesin-
associated protein that regulates dissociation of cohesin from
chromatin [16].
Previously, we generated and characterized Pds5B-deficient
mice and found that they die at birth with a constellation of
abnormalities reminiscent of those observed in patients with CdLS
[22]. The high frequency of mental retardation and behavioral
disorders in CdLS suggests that cohesin abnormalities lead to
neuronal dysfunction. In accord, we found high expression of
PDS5B in post-mitotic neurons as well as deficits in neuronal
migration and axonal projection in Pds5B-deficient mice. We also
noted the absence of sister chromatid cohesion deficits in cells from
these mice, again consistent with findings in CdLS patients.
Overall, these observations indicate that cohesin proteins have
multiple roles that together shape the development of multi-
cellular organisms.
Similar to human CdLS, Pds5B mutant mice exhibit variable
expressivity of phenotypes, but unlike human CdLS, Pds5B mutant
mice do not have diaphragmatic hernia or eye or kidney
abnormalities, which are associated with CdLS. It is possible that
Pds5A may have compensated for Pds5B loss or these defects may
be dependent solely on Pds5A activity or require marked reduction
in total PDS5 activity. To explain the variable expressivity
observed in Pds5B-deficient mice and CdLS cases, we hypothe-
sized that Pds5A may be partially compensating for Pds5B loss. To
this end, we generated and characterized Pds5A-deficient mice and
found that they manifest multiple developmental defects. Many of
the abnormalities are similar to those present in CdLS patients and
Pds5B-deficient mice, suggesting functional redundancy between
PDS5A and PDS5B in embryonic development. The CdLS-like
developmental anomalies in Pds5A, B-deficient mice along with the
involvement of PDS5A and PDS5B in the same molecular
complex as NIPBL, SMC1A, SMC3, prompted us to explore
whether PDS5A and PDS5B mutations are associated with CdLS.
We sequenced the PDS5A and PDS5B gene from genomic DNAs
of NIPBL and SMC1A mutation negative CdLS patients and
identified a missense mutation (R1292Q) that disrupts PDS5B
DNA-binding and likely causes or contributes to a familial case of
CdLS. These findings provide strong evidence that the functions of
PDS5 proteins and associated cohesin are crucial for normal
mammalian development.
Results
Pds5A deficiency results in developmental abnormalities
similar to those present in Pds5B mutant mice
Because Pds5B mutant mice exhibit phenotypic variability and
incomplete penetrance [22], we hypothesized that Pds5A might
partially compensate for mutant Pds5B function. To test this
hypothesis and to determine the role of Pds5A, we generated
Pds5A-deficient mice using ES cells with an insertion of the b-geo
transgene in the second intron (Baygenomics genetrap line
RRM243, See Fig. S1 in Supplementary Data and Materials
S1). Quantitative RT-PCR analysis revealed universal expression
of both Pds5A and Pds5B during embryonic development (See Fig.
S2 in Supplementary Data and Materials S1). In adulthood, Pds5A
is expressed at similarly low levels in all tissues (See Fig. S3A in
Supplementary Data and Materials S1), whereas adult expression
of Pds5B is more variable between tissues, with particularly high
levels observed in adult testis and brain [22]. Using the Pds5A-
deficient mice, we also examined the Pds5A expression pattern
using X-gal histochemistry to detect the mutant Pds5A-b-
galactosidase fusion protein created by gene trap. We detected
expression of b-galactosidase in most tissues, including the nervous
system where Purkinje cells in the cerebellum and neurons in the
cerebral cortex and retina had strong X-gal staining (See Fig. S3 in
Supplementary Data and Materials S1). We also found high Pds5A
mRNA and protein levels in cultured dorsal root ganglia and
hippocampal neurons, supporting the idea that PDS5 proteins
play important roles in post-mitotic neurons (data not shown).
To determine the impact of Pds5A loss during development we
bred heterozygous Pds5A animals to obtain Pds5A null animals. We
found that Pds5A-deficient mice die perinatally, and are signifi-
PDS5 Essential for Development
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littermates (Fig. 1A), even though no overt structural abnormalities
were observed (Fig. 1B). To examine the skeleton, we stained
newborn pups with Alcian Blue and Alizarin Red S to highlight
the cartilage and bones. We detected several defects with
incomplete penetrance and variable expressivity including cleft
palate (20/61 in Pds5A
2/2, 4/77 in Pds5A
+/2, 0/39 in Pds5A
+/+;
Fig. 1C–F), presence of cervical ribs (10/10 in Pds5A
2/2, 0/11 in
Pds5A
+/+; fusion of C7 and T1 or transformation of C7 to T1;
Fig. 1G–J),abnormalsternum (5/10 inPds5A
2/2,0/ 25inPds5A
+/+;
Fig. 1K–N) and abnormal patterns of vertebral ossification (17/26
in Pds5A
2/2, 0/7 in Pds5A
+/2, 0/3 in Pds5A
+/+; Fig. 1O, P).
Many of these defects were similar to those observed in Pds5B
mutant mice, indicating that both PDS5 proteins have
important roles in skeletal patterning and palatogenesis.
Interestingly, both mouse mutants had variable penetrance
and expressivity of these skeletal defects suggesting that total
Pds5 dosage is critical for palatogenesis and skeletal patterning.
The importance of Pds5 dosage is further highlighted by the
frequency of cleft palate, which is 33% (20/61) in Pds5A
homozygotes and 5% (4/77) in Pds5A heterozygotes, a finding
consistent with the idea that reduced dosage of functional cohesin
results in the developmental anomalies characteristic of CdLS.
Renal anomalies are also associated with CdLS [1] and PDS5A
has been implicated in renal growth [33]. These reports and the
high renal expression of Pds5A in newborn and adult mice (See
Fig. S3A, F in Supplementary Data and Materials S1) prompted
us to examine renal development in Pds5A-deficient mice. We
found that ,13% (8/61) of Pds5A-deficient mice have either
unilateral or bilateral kidney agenesis (Fig. 1Q). Furthermore,
when kidneys do develop in these mutant mice, they are
hypoplastic and have a reduced number of glomeruli (Fig. 1R).
The defects in embryonic renal development could contribute to
the perinatal lethality of the Pds5A-deficient animals.
Pds5A-mutant mice have normal sympathetic neuronal
projections and germ cell differentiation
Cohesin components are crucial for axonal projection and
neuronal migration in mice (PDS5B) [22], axonal pruning and
dendritic targeting in Drosophila (SMC1, RAD21, and SA) [24,25],
axonal guidance in C. elegans (MAU-2/SCC4) [18], and nervous
system development in zebrafish (SMC1, RAD21) [20]. The
expression of Pds5A in post-mitotic neurons (See Fig. S3 in
Supplementary Data and Materials S1), the role of other cohesin
components in neuronal development and function, and the
mental retardation and behavioral abnormalities associated with
CdLS, encouraged us to examine the nervous system in Pds5A
2/2
mice. Consistent with the largely normal brain anatomy observed
in CdLS patients and in Pds5B-deficient mice, we did not observe
any gross or microscopic structural anomalies in Pds5A
2/2 brain.
Cultured hippocampal neuron developed normally (data not
shown) with no obvious defects in survival or polarity (Fig. 2A and
B). These data suggest that PDS5A does not play obvious roles in
embryonic central nervous system development.
The defects in sympathetic innervation emanating from the
superior cervical ganglion (SCG) observed in Pds5B-deficient mice
could explain the ptosis frequently associated with CdLS [1]. In
contrast to Pds5B-deficient mice, the sympathetic nervous system
in Pds5A
2/2 mice was unremarkable, with a well developed SCG
that was positioned appropriately and had normally appearing
neuronal projections (Fig. 2C and D).
Pds5B-deficient mice have severe depletion of primordial germ
cells in the testes and ovaries and some cases of CdLS also exhibit
significant reduction or absence of germ cells [22,34]. An
examination of Pds5A
2/2 mice revealed normal germ cell
development with similar numbers of germ cells in both the testes
and ovaries of wildtype and Pds5A
2/2 P0 mice (Fig. 2E and F; See
Fig. S4 in Supplementary Data and Materials S1). To further
examine whether PDS5A might regulate sister chromatid cohesion
during meiosis, a histological analysis of gonadal germ cells in P0
female mice was performed. We found that most germ cells in
both Pds5A-deficient and wildtype ovaries demonstrated the
distinctive nuclear morphology with condensed chromosomes that
characterize the zygotene and pachytene stages of meiotic
prophase (See Fig. S4A, B in Supplementary Data and Materials
S1). We also examined spermatogenesis, using testicular trans-
plantation [22] to propagate E18.5 testis as explants on the backs
of nude mice. We found similar numbers of spermatogonia and
round spermatids in wildtype and Pds5A mutant transplanted
testes 4 weeks after transplantation (n=4; See Fig. S4C,D in
Supplementary Data and Materials S1). By 6 weeks after
transplantation, the explanted Pds5A
2/2 testes contained testicular
cords with the full spectrum of spermatogenesis (n=5; Fig. 2 G,
H), including mature spermatids with condensed heads and
elongated tails (See Fig. S4E,F in Supplementary Data and
Materials S1). Together, these data indicated that Pds5A is not
required for meiosis or primordial germ cell development.
Pds5 gene dosage affects mouse embryonic
development: phenotypic defects in Pds5A
+/2; Pds5B
2/2
mice and Pds5A
2/2;Pds5B
+/2 mice
Pds5B-deficient cells do not display defects in chromosome
cohesion, suggesting that the developmental abnormalities in
Pds5B mutant mice arise from the lack of other, non-canonical
PDS5B functions [22]. To test for cohesion defects in Pds5A-
deficient cells, we obtained MEF lines (n=3) from Pds5A-deficient
and wildtype embryos. Both Pds5A-deficient and wildtype MEFs
proliferate at the same rate (data not shown), and the levels of the
cohesin components SMC3 (Fig. 3A) and SCC1 in these cells were
equivalent (data not shown). We performed metaphase chromo-
some analysis by GTG (giemsa-banding using trypsin and giemsa)
banding of these mutant MEFs. We analyzed .50 metaphase cells
per line and found no obvious cohesion defects such as precocious
sister chromatid separation (PSCS) or gross chromosomal
abnormalities in Pds5A
2/2 MEFs (data not shown). The lack of
sister chromatid cohesion abnormalities in cells lacking either
PDS5A or PDS5B suggests that they have redundant functions in
sister chromatid cohesion and that their roles in mammalian
embryonic development are unlikely to be related to their role in
cohesion.
The phenotypic overlap between Pds5A- and Pds5B-deficient
mice also suggests the possibility of redundant functions between
these two closely related homologs during development. To study
the effects of PDS5 dosage on sister chromatid cohesion and
embryonic development, we crossed Pds5A
+/2 with Pds5B
+/2 to
obtain compound heterozygotes. These were then used to generate
double homozygous or compound homozygous-heterozygous
mice (i.e. mice with only one wild type Pds5 allele, either Pds5A
or Pds5B). No Pds5A
2/2;Pds5B
2/2 double homozygous embryos
were obtained at E9.5 (Fig. 3D), indicating that depletion of both
Pds5A and Pds5B leads to very early embryonic lethality. However,
Pds5A
+/2;Pds5B
2/2 and Pds5A
2/2;Pds5B
+/2 embryos were iden-
tified, but had severe growth retardation and died between E11.5
and E12.5. The phenotype of these mutant embryos clearly
demonstrated the redundant effects of PDS5A and PDS5B on
heart, enteric nervous system, and lens development (Fig. 3D).
To ascertain whether low levels of PDS5 proteins can affect
sister chromatid cohesion, cohesin stability or cohesin chromo-
PDS5 Essential for Development
PLoS ONE | www.plosone.org 3 May 2009 | Volume 4 | Issue 5 | e5232Figure 1. Pds5A deficiency results in growth retardation, abnormal skeletal patterning and cleft palate. (A) The weight of Pds5A
2/2 P0
mice is significantly lower than that of wildtype and heterozygous littermates (WT, n=8; Pds5A
+/2, n=30; Pds5A
2/2, n=39). Error bars represent
s.e.m.
*P,0.001, Student’s unpaired, two tailed t-test. (B) Morphology of wildtype and Pds5A mutant mice. Note that newborn Pds5A
2/2 pups (right)
were smaller than their wildtype littermates (left). Note too the absence of milk in the stomach of the Pds5A
2/2 pup. Scale bar: 0.5 cm. (C, D) Alizarin
Red S and Alcian Blue staining of neonatal skulls demonstrates complete cleft palate (arrows) of a Pds5A
2/2 neonate (D) compared with the proximity
of palatal bones in the midline (arrow) in the wildtype control (C). Scale bar: 0.5 mm. (E, F) Palatogenesis defects illustrated using H&E stained coronal
sections of E18.5 wildtype (E) and Pds5A
2/2 (F) embryos. ps, palatal shelf; n, nasal bone; t, tongue. Arrows in F point to the unfused palatal shelves.
Scale bar: 1 mm. (G–P) Alizarin Red S and Alcian Blue staining of newborn skeleton. Bone is stained red and cartilage is stained blue. (G–J) Cervical
and thoracic vertebrae and ribs. Note the C7-T1 fusions (arrows in H, I) and cervical rib (arrow in J) in Pds5A
2/2 mice, compared to the normal skeletal
patterning in wildtype animals (G). Cervical (C) and Thoracic (T) vertebrae are marked by numbers. (K–N) Sternum morphology. Arrows denote
ectopic rib-sternum conjunctions (L–N) in Pds5A
2/2 mice compared to sternum patterning in wildtype (K). (O, P) Morphology of the first cervical
vertebrae. Note the unfused ossification centers at the dorsal tip of the first cervical vertebrae (arrows) in Pds5A
2/2 animal (P) compared to wildtype
(O). Scale bar for G–N: 1 mm; scale bar for O–P: 0.5 mm. (Q, R) Renal abnormalities in neonatal Pds5A-deficient mice. (Q) Bilateral renal agenesis in
Pds5A
2/2 newborn animals. AG, adrenal gland. Scale bar: 1 mm. (R) The total number of glomeruli in kidneys from P0 Pds5A
2/2 and wildtype mice
were counted (n=4 animals, 8 kidneys). (
*, P,0.05, student unpaired t test; mean6s.e.m.).
doi:10.1371/journal.pone.0005232.g001
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PLoS ONE | www.plosone.org 4 May 2009 | Volume 4 | Issue 5 | e5232Figure 2. Normal development of hippocampal neurons, the superior cervical ganglion, and germ cells in Pds5A
2/2 mice. (A, B)
Hippocampal neurons from wildtype and Pds5A mutant mice were cultured for 3 days and stained with TuJ1 antibody. The neurons show normal
axonal projection and polarity (one axon per neuron). Arrowheads, cell bodies; arrows, axons. (C, D) Tyrosine hydroxylase (TOH) whole-mount
staining of sympathetic projections from the superior cervical ganglion in wildtype (C) and Pds5A mutant (D) mice showed that the carotid nerves
(indicated by arrows) project normally to the eye. ey, eye; ea, ear. (E, F) H&E staining of germ cells in neonatal testes showed similar numbers of germ
cells in wildtype (E) and Pds5A
2/2 (F) mice. Arrows point to testicular cords surrounding the germ cells. (G, H) H&E staining of 6-week testes
transplants of E18.5 wildtype (G) and Pds5A
2/2 mice (H). Note the presence of elongated spermatids with condensed heads and long tails in both
wildtype and Pds5A
2/2 testis explants (arrows).
doi:10.1371/journal.pone.0005232.g002
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PLoS ONE | www.plosone.org 5 May 2009 | Volume 4 | Issue 5 | e5232some-binding dynamics, we studied MEFs prepared from Pds5A
2/
2;Pds5B
+/2 and Pds5A
+/2;Pds5B
2/2 embryos. The analysis of
metaphase spreads of these MEFs did not show any abnormalities
in sister chromatid cohesion (Fig. 3B). We then used fluorescence
recovery after photobleaching (FRAP) assays to compare the
dynamics of association of a SCC1-EGFP fusion protein with
chromosomes in mutant and wildtype MEFs. We found that
fluorescence recovery dynamics of SCC1-EGFP in wildtype,
Pds5A
2/2;Pds5B
+/2, and Pds5A
+/2;Pds5B
2/2 MEFs all showed
similar slow recovery curves (Fig. 3C; See Fig. S5A in
Supplementary Data and Materials S1) with a time scale consistent
with previous reports [35]. We also found no significant differences
Figure 3. Pds5 gene dosage synergistically affects development but does not cause defects in sister chromatid cohesion or cohesin-
chromatin association. (A) Overall cohesin levels in E14.5 kidney lysates were assessed by Western blotting using anti-SMC3 antibodies. ß-tubulin
levels were used to confirm equivalent protein loading. Note that SMC3 levels were equivalent in tissues from wildtype and Pds5A
2/2 mice. (B)G T G
(giemsa-banding using trypsin and giemsa) banded metaphase spreads from mouse embryonic fibroblasts (MEFs) derived from wildtype and Pds5A
2/2;
Pds5B
+/2 mice showed no evidence of precocious sister chromatid separation (PSCS). (C) Fluorescent Recovery After Photobleaching (FRAP) using SCC1-
EGFP in wildtype and Pds5A
2/2;Pds5B
+/2 MEFs. Half of the nucleus was bleached and fluorescence intensity was measured every 30 sec for 30 min. The
images show the recovery dynamics over time. Note no significant difference of cohesin recovery dynamics between wildtype and Pds5A
2/2;Pds5B
+/2
cells after photobleaching. (D) A summary table listing the abnormalities associated with Pds5 deficiencies demonstrates the genetic interactions
between Pds5A and Pds5B. The left diagram displays the age when most embryos of the indicated genotype died. The right table lists the phenotypes
observed in the indicated embryos. Hom, homozygote; het, heterozygote; wt, wild type; GD, growth delay; CP, cleft palate; SPD, skeletal patterning
defects; CHD, congenital heart defects; PNSD, peripheral nervous system defects; LD, lens development defects; PGCD, primordial germ cell defects;C D ,
cohesion defects; KD, kidney developmental defects. +, presence of the indicated phenotype; - absence of the indicated phenotype; ND, not determined;
N/A, not applicablesince noembryos wereobtainedfor double homozygous mutants. *, Pds5A homozygotes havedelayed ENS precursor migration, but
normal SCG projection. [+], highlights functional redundancy and diversification of PDS5A and PDS5B.
doi:10.1371/journal.pone.0005232.g003
PDS5 Essential for Development
PLoS ONE | www.plosone.org 6 May 2009 | Volume 4 | Issue 5 | e5232in residence times of either weak or strong chromatin-bound
SCC1-EGFP between wildtype and Pds5 mutant MEFs (See Fig.
S5B in Supplementary Data and Materials S1). There is a similar
composition of soluble SCC1-EGFP as well as weak and strong
chromatin-bound SCC1-EGFP proteins between wildtype and
Pds5 mutant MEFs (See Fig. S5C in Supplementary Data and
Materials S1) was also observed. These results indicate that cells
with only one Pds5 wildtype allele (either Pds5A or Pds5B) have
normal cohesin stability and cohesin-chromatin association
dynamics and imply that embryonic development is more sensitive
than sister chromatid cohesion to levels of PDS5 activity.
Both PDS5A and PDS5B are important for cardiac
development
Congenital heart defects (CDH), primarily atrial septal defects,
are frequently observed in children with CdLS (range 14–70% in
different studies) [36]. Similar types of CHDs are present in
Pds5B
2/2 mice [22]. Pds5A
2/2 mice suffer from respiratory
distress and die within a few hours after birth, suggesting that they
may also have cardiac anomalies. Indeed, we found that Pds5A
2/2
mice, compared to wildtype mice, had significantly higher
incidence of congenital heart defects (17/25 versus 3/18,
P,0.001; Fig. 4A–D, See Table S1 in Supplementary Data and
Materials S1), including those that are commonly found in CdLS
patients [1] and Pds5B-deficient mice [22].
In Pds5A
2/2 mice, we identified atrial septal defect of the
secundum type (ASD, 1/25), isolated ventricular septal defects
(VSDs, 10/25; all perimembranous), double outlet right ventricle
(DORV, 1/25), and atrioventricular canal defects (AVCDs, 5/25)
(Fig. 4A–D; See Table S1 in Supplementary Data and Materials
S1). All of these defects, except for ASD, would be expected to
cause excessive pulmonary circulation and edema from left-to-
right shunting of blood at the ventricular level, thus resulting in
respiratory distress and potentially contributing to the early
postnatal lethality.
Heterozygous Pds5A mice (5/19) also had heart defects that
were more severe than those in wildtype littermates. For instance,
we identified Pds5A heterozygotes with tetralogy of Fallot (TOF, a
common malformation in CdLS, which was also associated with
an ASD; 1/19), ASD alone (3/19), or VSD (1/19) (See Table S1
in Supplementary Data and Materials S1).
Interestingly, we identified small VSDs in 3/18 wildtype
littermates derived from Pds5A heterozygote breedings. This is
significantly higher than seen in wild-type controls in other mouse
models of congenital heart disease (,1%; Jay PY, unpublished
observations). This observation suggests that parental Pds5A
heterozygosity could adversely affect the genetic stability of
gametes, perhaps by causing aneuploidy or epigenetic changes
that increase the frequency of developmental defects in the
progeny. This hypothesis is supported by the recent evidence that
maternal CTCF, whose function may be mediated via cohesin
complexes [23,28], is essential for proper oocyte meiosis and
embryonic development [37].
The high expression of both Pds5A and Pds5B in the embryonic
heart along with the presence of cardiac defects in both Pds5A- and
Pds5B-deficient mice emphasizes the crucial function of PDS5
activity in cardiac development. To further explore the conse-
quences of PDS5 loss in the heart, we examined Pds5A
2/2;
Pds5B
+/2 or Pds5A
+/2;Pds5B
2/2 E12.5 embryos. All embryos
lacking three Pds5 alleles (n=4) had severe cardiac abnormalities
including truncus arteriosus (TA) and a common atrioventricular
canal. The endocardial cushions of the outflow tract failed to
develop separate aortic and pulmonic valve leaflets, and the
aorticopulmonary septum was absent (Fig. 4E, F). An underlying
defect in neural crest-derived cell migration likely contributes to
these abnormalities of outflow tract development [38]. The
common atrioventricular canal defect was marked by severe
hypoplasia or aplasia of the ventricular septum and a failure of
valve development from the atrioventricular canal cushion tissue
(Fig. 4G, H). Furthermore, all Pds5A
2/2;Pds5B
+/2 or Pds5A
+/2;
Pds5B
2/2 embryos had a thin compact ventricular myocardium
and dilated atria (Fig. 4I, J). The absence of competent
atrioventricular valves likely causes atrial dilation due to
regurgitant blood flow. In combination with a thin, dysfunctional
myocardium, forward cardiac output would be severely compro-
mised, leading to growth retardation and embryonic lethality.
Synergistic effects of PDS5A and PDS5B on enteric
nervous system (ENS) development
Pds5B-deficient mice have severe ENS defects, including
delayed enteric neuron precursor migration and distal colon
aganglionosis [22]. To assess the contribution of PDS5A to ENS
development, we performed whole mount staining of Pds5A
2/2
fetal gut using TuJ1 antibody, a marker for enteric neurons. By
E12.5, enteric neurons had colonized the entire small bowel and
half of the colon in wildtype embryos. In contrast, in Pds5A
2/2
mice, ENS precursors had failed to migrate much beyond the
ileocecal (IC) junction (Fig. 5A and B). To determine the effect of
losing three Pds5 alleles on ENS development we also examined
the ENS in E12.5 Pds5A
2/2;Pds5B
+/2 mice and found that they
had slightly more extensive distal bowel aganglionosis than
Pds5A
2/2 mice (Fig. 5A–D) suggesting that there is a Pds5 gene
dosage effect on ENS development. To extend this observation we
examined the ENS in Pds5A
+/2;Pds5B
2/2 mice. Because most of
these animals die at E11.5, the ENS analysis in these mice was
performed at this early stage of development Remarkably, in
Pds5A
+/2;Pds5B
2/2 mice (n=6) we observed very few enteric
neurons distal to the stomach, suggesting severe migratory deficits
in these mutant ENS precursor cells (Fig. 5E–H). To confirm that
heterozygosity for Pds5A synergistically exacerbates the ENS
defects caused by Pds5B-deficiency, we examined Pds5B
2/2
animals at this age and found abnormal, but less severe distal
bowel aganglionosis. Collectively, these data demonstrate that
both PDS5A and PDS5B have important roles in ENS
development, but that PDS5B-deficiency causes more severe
abnormalities than lack of PDS5A.
PDS5 proteins regulate lens development
In analyzing the E11.5 and E12.5 Pds5A
2/2;Pds5B
+/2 and
Pds5A
+/2;Pds5B
2/2 embryos, we found a striking defect in lens
development, either lens hypoplasia or agenesis (Fig. 6A–D, I, J),
that was not observed in Pds5A-o rPds5B-deficient mice.
Interestingly, Pds5A
2/2;Pds5B
+/2 embryos frequently have lens
agenesis, whereas Pds5A
+/2;Pds5B
2/2 embryos usually have
hypoplastic lenses. An immunohistochemical analysis revealed
that PDS5A is highly expressed in head surface ectoderm at E9.5,
a stage when the lens is beginning to form (Fig. 6E), whereas
PDS5B expression was weak (data not shown). These results
suggest that lens formation is more dependent on Pds5A, whereas
Pds5B plays a more crucial role in ENS development.
To further explore the mechanism of aberrant lens development,
we performed a histological examination of E10.5 Pds5A
2/2;
Pds5B
+/2 embryos. This revealed diminished contact between
the lens placode and optic vesicle (Fig. 6G and H), suggesting
that PDS5 proteins are important for this initial contact and the
lens induction that follows. Further morphological analysis
showed that Pds5A
2/2;Pds5B
+/2 mice had optic vesicles of
normal thickness, but with a distorted shape (as seen in Fig. 6H).
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PLoS ONE | www.plosone.org 8 May 2009 | Volume 4 | Issue 5 | e5232The peripheral regions of the lensplacode were thinnerthan normal
(data not shown) and fewer cells were present in this area. A BrdU
labeling experiment however showed that the percentage of
proliferating cells in the placode was similar in wildtype and
Pds5A
2/2;Pds5B
+/2 mice (Fig. 6F–H). These observations suggest
that the abnormal shape of the optic vesicle resulted in decreased
contact between it and the surface ectoderm, resulting in a smaller
lens placode or failure of lens induction.
Figure 5. Synergistic effects of Pds5A and Pds5B deficiencies on enteric nervous system development. (A–C) Whole mount TuJ1
immunofluorescent antibody staining of E12.5 gut highlights the enteric neurons (A, Pds5A
+/2;B ,Pds5A
2/2;C ,Pds5A
2/2;Pds5B
+/2). White bars define
the ileocecal junction and an asterisk denotes the end of the colon. Enteric neurons colonize the bowel to the mid-colon in wildtype mice (A), but
migrate only to the proximal colon or ileocecal junction in Pds5A
2/2 (B) and to near the ileocecal junction in Pds5A
2/2;Pds5B
+/2 mice (C). Scale bars:
10 mm. (D) Schematic representation of the extent of bowel colonization by enteric neurons Pds5A
2/2 mice at E12.5. [WT (n=8), Pds5A
2/2 (n=6), and
Pds5A
2/2;Pds5B
+/2 (n=3)]. The scale at the top corresponds to the percentage of the respective intestinal segment (small or large intestine)
successfully colonized by neurons. (E–G) Whole mount TuJ1 immunofluorescent antibody staining of E11.5 gut highlights the enteric neurons in (E)
Pds5A
+/2, (F) Pds5B
2/2 and (G) Pds5A
+/2;Pds5B
2/2 mutant mice. White bars define the ileocecal junction and an asterisk denotes the end of the colon.
Note that the enteric neuron migration wavefront in wildtype mice reaches the ileocecal junction at this age while migration was delayed in Pds5B
2/2
mice. In Pds5A
2/2;Pds5B
+/2 mice only a few enteric neurons in the stomach were detected and none had migrated into the intestine. Scale bars: 10 mm.
(H) Schematic representation of ENS defects in Pds5A
+/2;Pds5B
2/2 mice at E11.5 [WT (n=4),Pds5B
2/2 (n=4),Pds5A
+/2;Pds5B
2/2 (n=6)]. The scale at the
top corresponds to the percentage of the respective intestinal segment (small or large intestine) successfully colonized by neurons.
doi:10.1371/journal.pone.0005232.g005
Figure 4. Pds5A mutant mice manifest cardiac abnormalities similar to those observed in CdLS. (A) A section of a wildtype mouse heart
demonstrates the intact ventricular septum and its relationship to the aortic and tricuspid valves.. (B–D) Sections of Pds5A mutant hearts showing: (B)
a perimembranous ventricular septal defect (VSD); (C) the pulmonary valve and artery in a heart with double outlet right ventricle; (D) the aorta
arising from the right ventricle of the same heart with a muscular conus between the aortic and mitral valve (arrowhead). Arrows indicate the
respective defects. Scale bar: 0.5 mm. (E–J) Severe cardiac defects in Pds5A
+/2;Pds5B
2/2 and Pds5A
2/2;Pds5B
+/2 embryos. (E) A section from wildtype
E12.5 embryonic heart shows the separation of aorta and pulmonary artery and the developing aortic valves (arrow). (F) A Pds5A
2/2;Pds5B
+/2 E12.5
embryonic heart shows the underdeveloped endocardial cushion of the outflow tract and the non-septated aorta and pulmonary artery (i.e., truncus
arteriosus). (G) Normal association of the atrial and ventricular septae with the endocardiac cushion and valve morphogenesis in a wildtype E12.5
heart. (H) A Pds5A
+/2;Pds5B
2/2 E12.5 heart demonstrates the dilated atria and underdeveloped endocardial cushion with no valve formation, and
failure of atrioventricular canal septation. (I) Wildtype E12.5 heart with a compact myocardial layer of normal thickness. (J) A Pds5A
2/2;Pds5B
+/2 heart
has a thin compact myocardium. Double-headed arrows in (I, J) indicate the compact myocardial layer. Ao, aorta; PA, pulmonary artery; RA, right
atrium; LA, left atrium; RV, right ventricle; LV, left ventricle; EC, endocardial cushion; T, trabecular myocardium; C, compact myocardium.
doi:10.1371/journal.pone.0005232.g004
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PLoS ONE | www.plosone.org 10 May 2009 | Volume 4 | Issue 5 | e5232The developmental deficits caused by mutations in cohesin are
likely due to changes in gene expression. To examine this
possibility in the lens, we examined the expression of two
transcription factors, Pax6 and Sox2, which regulate lens
development. Immunostaining was performed on E9.5 and
E10.5 eye sections; however no differences in expression were
observed (data not shown). We next examined the expression of
aA-crystallin, an abundant lens protein that serves as a marker for
lens formation. We found that most cells in the hypoplastic
Pds5A
+/2;Pds5B
2/2 lens do not express aA-crystallin (Fig. 6I and
J). These results suggest that PDS5 proteins help regulate aA-
crystallin expression; however, its loss could also be due to
aberrant post-transcriptional regulation or other indirect effects of
PDS5 dysfunction. Nonetheless, the lens developmental abnor-
malities in Pds5-deficient mice provide a potential mechanism for
how abnormal cohesin activity could cause the myopia associated
with CdLS.
A PDS5B mutation that disrupts DNA-binding
contributes to a familial case of CdLS with megacolon
Mutations affecting multiple cohesion factors, namely NIPBL,
SMC1A, and SMC3 have been identified in CdLS patients,
indicating that aberrant cohesin function is responsible for the
anomalies associated with this syndrome. The discovery that
Pds5B- and Pds5A-deficient mice exhibit developmental abnor-
malities resembling CdLS, prompted us to screen patients with
CdLS for PDS5 mutations. We sequenced all exons of PDS5B and
PDS5A and their adjacent intronic sequences that harbor splicing
signals in 114 individuals with CdLS that had been screened
previously for mutations in NIPBL, SMC1A and SMC3 (See Table
S2 and S3 in Supplementary Data and Materials S1 for primer
information). More than a dozen polymorphisms were detected in
both PDS5A and PDS5B (See Fig. S7 and S8 in Supplementary
Data and Materials S1). While no pathologic mutations in PDS5A
were identified, we found one patient (CDL-238) with a G to A
substitution in exon 32 of a single PDS5B allele that creates a
missense mutation (R1292Q). This R1292Q substitution occurs at
an evolutionarily conserved residue within the invariant core
sequence (GRP) of the AT-hook DNA binding motif (Fig. 7A–C).
This mutation was not present in 432 control chromosomes. The
identification of only a single PDS5B mutation in this cohort of
CdLS patients suggests that PDS5B mutations account for a very
small portion of CdLS, a situation similar to that reported for
SMC3 [4].
The parents in the affected family are distantly consanguineous
and three of their children were diagnosed with CdLS while one
brother and both parents were clinically unaffected (Fig. 7D). We
sequenced exon 32 in all available family members and found that
two affected siblings (II-2 and II-3) carried the same mutation. In
addition, the unaffected brother and the unaffected father also
carried the mutation (I-1 and II-4, Fig. 7D). Another affected
sibling (II-1) was deceased and no DNA was available. The
affected family members showed a common combination of
symptoms in the CdLS spectrum, including typical facial
dysmorphisms (microbrachycephaly, arched eye brows, synophrys,
ptosis, and long philtrum, low posterior hairline, short neck, See
Fig. S9 in Supplementary Data and Materials S1), single palmar
creases, hirsutism, mental retardation, seizures, and growth
retardation (height and weight below the 3
rd centiles). The hands
were small, but no structural limb abnormalities were noted. In
addition, two of the affected siblings (II-2 and II-3) have developed
a severe form of megacolon, simlar to that observed in Goldberg-
Shprintzen syndrome (OMIM#609460). This family therefore
represents a familial CdLS case with atypical inheritance that
includes associations with megacolon and mutation of the PDS5B
gene. To further characterize the PDS5B inheritance in this family,
we performed SNPs arrays. We found that the two affected siblings
(II-2 and II-3) share the same maternal PDS5B allele, whereas the
unaffected brother (II-4) inherited a different maternal PDS5B
allele (See Table S4 in Supplementary Data and Materials S1).
This result suggests that CdLS is transmitted in a recessive manner
in this family and that a second mutation is likely to be present in
the maternal PDS5B allele that was not detected by our sequence
analysis.
The location of the R1292Q mutation within the AT-hook
domain in PDS5B suggests that it could be functionally significant.
The positively charged Arg within the core sequence of the AT-
hook domain in high mobility group (HMG) proteins has been
demonstrated by structural analysis and electrophoretic mobility
shift assays (EMSA) to be crucial for DNA binding [39,40]. To test
the effect of the R1292Q mutation on PDS5B function, we
performed EMSA using the C-terminal region containing the AT-
hook domains from both wildtype and R1292Q mutant PDS5B.
As reported for the AT-hook containing HMG-1, we found that
the PDS5B C-terminal region bound to the AT-rich DNA probe
efficiently and specifically. However, the C-terminal region
derived from PDS5B (R1292Q) had decreased DNA binding
affinity (Fig. 7E and See Fig. S10 in Supplementary Data and
Materials S1). Interestingly, we observed two DNA-protein
complex bands on our EMSA assays (Fig. 7E and See Fig. S10
in Supplementary Data and Materials S1), suggesting that the two
AT-hook motifs in PDS5B imbue it with multivalent binding
properties like that of HMG-1 [41]. While it has been previously
speculated but never demonstrated that PDS5 can bind DNA
[42], these results indicate that the R1292Q mutation disrupts the
DNA binding affinity of the C-terminal PDS5B AT-hook
domains. This presumably influences PDS5B-mediated transcrip-
tional regulation, and may affect cohesin activity and development
thus resulting in CdLS.
Discussion
The cohesin complex mediates sister chromatid cohesion during
cell division, regulates gene expression, and influences a broad
Figure 6. Pds5A
2/2;Pds5B
+/2 and Pds5A
+/2;Pds5B
2/2 mice display abnormal lens development. (A, B) H&E stained sections of eyes from
E12.5 wildtype and Pds5A
2/2;Pds5B
+/2 embryos. No lens was formed in the Pds5A
2/2;Pds5B
+/2 embryo (B), whereas the wildtype embryo has a clearly
formed lens at this stage (A). (C,D) Whole mount image of the eyes from E11.5 wildtype and Pds5 mutant embryos. Note that the Pds5A
+/2;Pds5B
2/2
eye (arrow, D) is much smaller than wildtype (white dashed circle, C). (E) Immunofluorescent staining of E9.5 eye using PDS5A antibodies
demonstrated that PDS5A is expressed at high levels in head surface ectoderm. HSE, head surface ectoderm; M, mesenchyme; OV, optical vesicle;
dashed lines, the boundaries among HSE, M, and OV. (F–H) Proliferating cells in the E10.5 eyes of wildtype (G) and Pds5A
2/2;Pds5B
+/2 (H) embryos
labeled with BrdU for 1 hr were detected using anti-BrdU antibodies. The eyes were counterstained with hematoxylin. Eye structures are as indicated
in G. Note that the lens placode is invaginating in wildtype (G) but not in Pds5A
2/2;Pds5B
+/2 embryos (H), although the percentage of BrdU positive
cells in both wildtype and mutant lens placodes was equivalent (F). (I,J) Immunohistochemical analysis using aA-crystallin antibodies of E11.5
wildtype and Pds5A
+/2;Pds5B
2/2 eyes. Note the small size and lack of aA-crystallin-positive cells in a Pds5A
+/2;Pds5B
2/2 lens (J) compared to strong
aA-crystallin expression in the majority of cells in a normal size, wildtype lens (I). R, retina; L, lens.
doi:10.1371/journal.pone.0005232.g006
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humans, subtle perturbations in cohesin activity contribute to
disorders now known as ‘cohesinopathies’, such as CdLS and
RBS, which are caused by mutations in NIPBL, SMC1A, SMC3,
and ESCO2. While ,50% of CdLS patients have identifiable
mutations in NIPBL, mutations in other cohesion components
(such as SMC1A and SMC3) appear to be much rarer (,5%),
leaving many clinically defined CdLS patients with no identified
Figure 7. PDS5B is mutated in a case of familial CdLS. (A) A schematic diagram of PDS5B showing the location of the R1292Q mutation within
the AT-hook domain. Red rectangles, HEAT repeats; grey rectangle, a leucine zipper domain; blue rectangles, AT-hook domains; thin black bars,
phosphorylation sites (Ser, Thr, and Tyr) in the C-terminal region of PDS5B. Note: See additional PDS5B structural analysis in supplementary data (See
Fig. S6 in Supplementary Data and Materials S1). (B) Sequencing traces displaying the G to A substitution (highlighted with an arrow) in one PDS5B
allele in the proband (compare traces of proband and control). This substitution results in an Arg to Gln transition at PDS5B residue 1292. (C)
Multispecies alignment of AT-hook domain from PDS5B and PDS5A. Note that the mutated Arg is highly conserved and located within the AT-hook
domain. Hs, Homo sapiens; Pa, Pan troglodytes; Ca, Canis familiaris; Mm, Mus musculus; Rn, Rattus norvegicus; Ch, Gallus gallus; Xe, Xenopus tropicalis; Br,
Danio rerio; Te, Tetraodon nigroviridis; Fu, Fugu rubripes.( D) The family tree of a proband (arrow) with three affected siblings (II-1,2,3, blackened circle
or square), one clinically normal brother (II-4), and two clinically normal parents (I-1 and I-2). One of the affected siblings was deceased and no DNA
was available from this individual (II-1). The father, two affected children, and one unaffected child carry the R1292Q mutation (depicted by blackened
symbol or small black dot). (E) The PDS5B(R1292Q) mutant has decreased DNA binding. EMSA using the T5-8-T5 AT-rich probe showed decreased
DNA binding by mutant PDS5B compared to wildtype PDS5B. The EMSA was performed with the indicated amounts of PDS5B protein (40, 20, 10,
5 ng). The specific nature of the binding was determined by EMSA competition assays (See Fig. S10 in Supplementary Data and Materials S1). Arrows,
protein-DNA complexes. C, control.
doi:10.1371/journal.pone.0005232.g007
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Pds5B exhibit a spectrum of developmental defects reminiscent of
those present in CdLS.
In this study, we sequenced the PDS5A and PDS5B genes in a
cohort of CdLS patients and identified a mutation in a conserved
motif (AT-hook domain) in PDS5B, which likely causes or
contributes to the disease. Our analysis of PDS5B has identified
two AT-hook domains [22] and a degenerative AT-hook domain
in PDS5A (See Fig. S6 in Supplementary Data and Materials S1).
We demonstrated that the PDS5B C-terminal region binds to an
AT-rich DNA sequence motif similar to that recognized by HMG-
1 [41], and that the CdLS-associated mutation in PDS5B at
R1292Q decreases PDS5B DNA-binding affinity. The association
of PDS5 with chromatin is dependent on functional cohesin in
Hela cells and Xenopus egg extracts [30], suggesting that the
PDS5B-DNA interactions demonstrated here may not be sufficient
for recruitment of PDS5B to chromatin in vivo. Instead, PDS5B
could interact with the cohesin core complex and modulate the
subchromatin distribution of chromatin-loaded cohesin through its
AT-hook domains. The acquisition of AT-hook domains in both
PDS5A and PDS5B during evolution may therefore reflect the
predilection of cohesin to interact with heterochromatin (i.e., AT-
rich) chromosomal regions. The AT-hook motif can also interact
with scaffold associated regions (SARs) [43,44] that can act as cis
regulatory elements for SATB1 and SATB2, transcription factors
that regulate skeletal patterning and palatogenesis [45,46].
The functional mutation of PDS5B we identified in a familial
CdLS case with atypical inheritance pattern is strongly suspected
to be pathogenic, although further studies using mice expressing
this mutant protein will be important in confirming its role in this
syndrome. The occurrence of the mutation in unaffected family
members has been previously demonstrated in one familial case of
CdLS with an SMC1A mutation [8] and could be explained by
three possibilities. First, the identification of a functional mutation
in PDS5B and the segregation of maternal alleles in a disease-
specific manner, as well as the recessive nature of the deficits in
Pds5B mutant mice suggest that CdLS in this family is caused by
compound heterozygosity of PDS5B mutations. In this case, the
second PDS5B mutation could be a point mutation in an intron or
in the regulatory region of PDS5B or other rearrangements like a
deletion or translocation that would not be detected by
sequencing.
A second possibility for the atypical genetic inheritance of
PDS5B mutation in this family is dominant inheritance with
incomplete penetrance. This is consistent with the variable
expressivity and penetrance observed in Pds5B-deficient mice,
suggesting that modifier genes or epigenetic factors contribute
significantly to PDS5B-regulated development. Genetic or epige-
netic modifers may be common in CdLS as there is significant
phenotypic variability among patients with the same mutation,
even within families [9–11]. In addition, the consanguinity of the
parents may provide recessive inheritance of a modifier locus (or
loci) whose homozygosity produces an environment whereby a
single mutant PDS5B allele leads to developmental deficits.
Finally, it is possible that this represents a digenic pattern of
inheritance. In this case, the other mutation could be present in
other cohesin proteins that regulate PDS5B function. An example
of such an inheritance pattern is Bardet-Biedl syndrome (BBS), a
rare oligogenic disorder exhibiting genetic heterogeneity with
primary cilium dysfunction [47]. Like CdLS, the BBS phenotype is
variable both between and within families. Interestingly, in some
cases of BBS, mutations in two cilium genes are required for
phenotypic penetrance [48]. A similar situation exists for
Hirschsprung disease, where hypomorphic mutations in both
RET and endothelin can interact to cause the characteristic ENS
deficits normally associated with heterozygous loss-of-function
mutations in these genes [49].
Perhaps the most consistent and striking abnormalities in Pds5
mutant mice concern the aberrant migration of ENS precursors
that results in intestinal hypoaganglionosis. This is not reported as
part of the constellation of symptoms in CdLS, but could be
related to the chronic constipation that is present in these patients
[50]. However, in this particular case these observations take on
added interest as affected members of this family also develop
severe megacolon. This disorder is similar to Hirschsprung disease,
which is most often caused by mutations in the RET tyrosine
kinase [51]. These symptoms are consistent with the distal colon
hypoganglionosis observed in Pds5B-deficient mice. This condition
becomes more severe with decreasing Pds5 gene dosage, at which
point it closely resembles deficits observed in Ret mutant mice [52].
Interestingly, Ret-deficient mice also have deficits in sympathetic
neurons that are similar to those present in Pds5B-deficient mice.
Furthermore, cohesin mutations in zebrafish block expression of
RUNX1, a transcription factor that regulates Ret expression in
mammals [20]. These findings suggest that Pds5B and Ret may act
on similar pathways to regulate neuronal development. Indeed,
the identification of PDS5B mutations in a family with CdLS and
megacolon suggests that PDS5B could be a modifier for
Hirschsprung disease and, that these two disorders may share
additional molecular pathways.
Cohesin functions along with the chromatin insulator protein
CTCF to regulate long-range enhancer-promoter communication-
mediated gene expression, possibly through stabilizing CTCF-
mediated chromosomal loops [53]. These long-range effects on
gene expression may be altered by defective cohesin function and
ultimately be responsible for the developmental abnormalities
present in CdLS and RBS. Cohesin and CTCF binding occurs at
loci containing the Dlx5 and Bdnf genes [23], which encode
proteins crucial for development of the skeleton and nervous
system. Interestingly, cohesin and CTCF are bound to the Bdnf
locus at several sites, including the promoter for isoform III, which
is regulated by MeCP2 in a neuronal activity-dependent manner.
Furthermore, the MeCP2-mediated expression of Dlx5 is depen-
dent on changes in chromosomal looping [54], suggesting a
potential mechanism by which mutations in cohesin components
(e.g., in CdLS) could be translated into aberrant neuronal
circuitry.
The Pds5A mutant mice have many developmental defects that
are similar to those present in Pds5B-deficient mice and in humans
with CdLS. Other phenotypes that are associated with Pds5B-
deficient mice, like defects in the ENS discussed above as well as
autonomic nervous system and primordial germ cell abnormalities
were not present (or as severe) in Pds5A-deficient mice, suggesting
both redundancy and/or diversification of the roles of PDS5
proteins during evolution. The broad spectrum of abnormalities
with variable expressivity in Pds5A- and Pds5B-deficient mice is
typical of CdLS [1], suggesting genetic, epigenetic or environ-
mental factors can influence the effects of cohesin dysfunction. The
striking phenotypes seen in these mice also suggest that additional
human disorders with similar phenotypic overlap could be caused
by mutations in PDS5A or PDS5B. Interestingly, the number of
human diseases caused by mutations in cohesion proteins
(cohesinopathies: CdLS, RBS/SC phocomelia, and Alpha thalas-
semia/mental retardation X linked (ATRX))[2,5,55] is growing.
The Pds5A- and Pds5B-deficient mice may be useful for the
identification of genetic modifiers and genetic pathways critical for
cohesin-regulated development that would constitute additional
targets for mutational analysis in cohesinopathies.
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embryos indicates that PDS5 function is essential for early
embryogenesis and may reflect its importance in mitosis or sister
chromatid cohesion. While loss of either Pds5A or Pds5B caused
neonatal lethality, the loss of three Pds5 alleles leads to mid-
gestational embryonic death. Although these embryos showed
striking defects in the enteric nervous system, heart, and lens, cells
with only a single remaining Pds5 allele did not manifest
precocious sister chromatid separation. These results suggest that
a low level of PDS5 protein is sufficient for chromosome cohesion
but is unable to sustain cohesin-mediated developmental gene
expression. The differential sensitivities of developmental gene
regulation and chromosome cohesion on cohesin dosage are
corroborated by observations in other model organisms. In
Drosophila, heterozygous mutants of either Nipped-B or Pds5 have
decreased expression of the homeobox cut gene without cohesion
abnormalities, whereas cohesion defects are present in the
homozygous mutants [21]. In zebrafish reduced cohesin levels
lead to abnormal Runx1 expression, indicating that cohesin levels
affect transcriptional regulation [20]. Finally, in humans, hetero-
zygous mutations in NIPBL, SMC1A,o rSMC3 lead to CdLS,
which is characterized by multiple developmental anomalies
without overt cohesion defects [4]. Although consistent with the
hypothesis that perturbed non-canonical functions of cohesin are
responsible for abnormalities present in cohesinopathies [2,3,56],
the lack of cohesion defects in cells with low levels of PDS5
proteins is in contrast to PDS5 functions in budding yeast, C.
elegans, and Drosophila. These organisms each contain a single PDS5
protein, and it plays a critical role in chromosome segregation
[13,21,57]. It should be noted, however, that only mild cohesion
defects were found in Hela cells when either PDS5A or PDS5B
were knocked down by RNAi [30]; again, suggesting that low
amounts of PDS5 protein are sufficient to support cohesion.
In summary, we have discovered that PDS5B is mutated in a
familial case of CdLS with megacolon, and that PDS5A and
PDS5B have both redundant and distinct roles in development
that are likely unrelated to its ancient function in sister chromatid
cohesion. The Pds5A- and Pds5B-deficient mice provide valuable
mammalian models to study molecular mechanisms of develop-
mental functions of the cohesin complex and the pathogenesis of
cohesinopathies.
Materials and Methods
Ethics Statement
All subjects enrolled in this study were consented under an IRB-
approved protocol of informed consent through The Children’s
Hospital of Philadelphia. All consents were written and signed by
the participants or by their parents or guardians in the case of
minors. All mouse experiments were performed under protocols
approved by the Washington University Animal Studies Commit-
tee.
Re-sequencing of PDS5B and PDS5A
All subjects were evaluated by one or more clinical dysmor-
phologists with experience with CdLS patients (supervised by Ian
Krantz, U. Penn). All of these samples were pre-screened by
investigators at U. Penn and found to have no mutations in NIPBL,
SMC1A, and SMC3 [2,4], thus they have unidentified genetic
alterations.
Using primer design software (Primer3), amplification primers
for each exon of PDS5B (36 exons) and PDS5A (33 exons) were
designed so that the intron-exon junctions as well as the entire
exon were sequenced in both directions (Tables S1 and S2)).
Forward primers contain M13 forward sequence at the 59 end and
reverse primers contain M13 reverse sequence at the 59 end so that
each amplicon could be sequenced with the universal M13
forward and reverse sequencing primers. Primers were ‘validated’
in a trial PCR reaction using control DNA to ensure that a single
fragment of predicted size was obtained. If a primer set failed to
amplify the anticipated product, new primers were designed for
the failed amplicon, and the process was repeated until specific
amplicons were obtained. The sequencing traces were analyzed in
Mutation Viewer (MV, bioinformatics core of Washington
University in St. Louis), and ‘high confidence’ sequence alterations
that did not coincide to polymorphisms present in SNP databases
were verified by examining the sequence traces directly.
Alterations that were clearly present were confirmed by re-
amplifying and sequencing the suspect amplicons.
Purification of Recombinant C-terminal PDS5B and
Electrophoretic Mobility Shift Assays
C-terminal human PDS5B (a.a. sequence: 1134–1446, either
wildtype or R1292Q mutant) was amplified by PCR using primers
(forward primer: 59-GCTAGTCATATGTACCCGTAC-
GACGTCCCGGACTACGCTTCTGAATTGGAGAAGCCTA-
GAGGCA-39 and reverse primer: 59-GCTAG-
TAAGCTTTCGCCGTTCCCTTTTAGCACT-39) and an N-
terminal HA tag was introduced. This fragment was cloned into
the pET30a(+) vector so that it also contained a C-terminal 6xHis
tag. BL21 Rosetta cells (Novagen) were transformed with this HA
and 6xHis tagged C-terminal PDS5B pET30a(+) vector and grown
to mid-log phase (OD600=0.6). Protein expression was induced
by addition of isopropyl-b-D-thiogalactopyranoside (final
conc.=150 mM) and the bacterial cells were lysed 2 hr later
using the cell lytic kit (Sigma). His-tagged PDS5B fusion proteins
were purified on nickel-nitrilotriacetic acid columns (Sigma).
Eluted proteins were concentrated using Amicon columns
(Millipore), and the concentration was determined using the
BCA protein assays (Pierce), equalized by dilution, and dialyzed
against Buffer A (50 mM Tris, pH 7.5, 0.5 mM EDTA, 100 mM
NaCl, 10% glycerol, 1 mM dithiothreitol) overnight. Electro-
phoretic Mobility Shift Assays (EMSA) were performed as
previously described [41]. Briefly, 20 ng of purified protein was
mixed with 2.25 pmol of
32P-labeled double-stranded oligonu-
cleotide probe (,30,000 cpm, T5-8- T5) and incubated at 25uC
for 5 min. The mixture was electrophoresed through a 6%
polyacrylamide gel and the shifted fragments were visualized by
autoradiography. Sequences of the oligonucleotides used to
make the T5-8-T5 DNA probes are: 59-GGACTCCAGGTC-
CAGGACCGCTTTTTGCGCGCGCTTTTTGCGGGAGGTC-
CAGCTGTCCACCTCC-39 and 59-GGAGGTGGACAGCTG-
GACCTCCCGCAAAAAGCGCGCGCAAAAAGCGGTCCTG-
GACCTGGAGTCC-39.
Immunohistochemistry and Western blot analysis
Tissues used in immunohistochemistry were fixed in paraformal-
dehyde/Bouin’s fixative. For antigen retrieval, paraffin-embedded
sections were de-paraffinized in xylene, hydrated and boiled in
1 mM EDTA solution for 30 min prior to immunostaining [22].
Primary antibodies used in this study include sheep anti-tyrosine
hydroxylase (1:200; Chemicon), anti-aA-crystallin (1:500; antibody
kindly provided by Usha Andley from hybridoma cells isolated by
Paul FitzGerald), and rabbit anti-PDS5A (1:1,000; Bethyl Labora-
tories, Montgomery, TX). The signals were visualized using donkey
anti-sheep HRP (1:200; Jackson immunoresearch), donkey anti-
mouse HRP (1:100, Jackson immunoresearch), or goat anti-rabbit
Cy3 (1:500; Jackson ImmunoResearch) secondary antibodies.
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and proteins derived from E18.5 kidney. The kidneys were
homogenized in 26SDS protein lysis buffer (100 mM Tris-HCl,
pH 6.8, 4% SDS, 16 protease inhibitor cocktail (Roche)) and
40 mg of total protein was loaded onto the gel. The blots were
probed with rabbit anti-PDS5A antibody (1:10,000 dilution;
Bethyl Laboratories, Montgomery, TX), mouse monoclonal anti-
b-galactosidase (1:1000 dilution, from Roche), or rabbit anti-
SMC3 antibody (1:1000 dilution; kindly provided by Rolf
Jessberger from Dresden University of Technology). The signals
were visualized using species-specific HRP conjugated secondary
antibodies and chemiluminescence substrate (Pierce). For a
loading control, mouse anti-b-tubulin antibody (DSHB, University
of Iowa, IA) was also used at 1:20,000 dilution.
Histological analysis of bone and palate
Alizarin Red S and Alcian Blue staining of newborn mice was
performed as previously described [22]. Briefly, newborn mice
were de-skinned and dehydrated in 95% EtOH. They were then
stained in Alcian blue solution for 3 d, rehydrated and incubated
in 1% KOH for 2 d, and stained for Alizarin Red S for 3 d. For
embryonic and newborn heads, fixation was carried out in 4%
paraformaldehyde at 4uC for 16 h. The fixed heads were properly
oriented in paraffin and coronal sections were prepared. The
sections were stained with Hematoxylin and Eosin (H & E) and
examined microscopically for evidence of cleft palate.
Analysis of germ cells, testes transplantation, and the
renal system
Embryonic gonads were dissected, fixed in Bouin’s solution
overnight at 4uC, embedded in paraffin, and 6 mm sections were
prepared. Germ cells were examined by H&E staining.
Testes from E18.5 mutant and wild-type mice were transplanted
subcutaneously onto the back/flank of castrated 4- to 8-wk-old
male nude mice (Taconic #NCRNUM, Germantown, NY) as
previously described [58]. The grafted donor testes were harvested
and processed for histological evaluation at the indicated time
points. To determine relative nephron numbers, we serially
sectioned E18.5 kidneys in their entirety and counted glomeruli
every 120 mm [52].
Analysis of cardiac malformations
The E12.5, E18.5, or newborn thorax was fixed in 4%
formaldehyde before the entire thorax or dissected heart was
embedded in paraffin. The tissue blocks were serially sectioned
completely at 6 mm thickness, hematoxylin and eosin stained, and
inspected for defects [22].
Nervous system analysis of Pds5 mutant mice
Dissociated hippocampal neurons from E15 mouse embryos
were cultured in Neurobasal medium with B27 (Invitrogen). The
anti-mitotic reagent, 5-Fluoro-29-deoxyuridine (FDU) (Sigma
#F0503), was used at a final concentration of 20 mM for the
first three days of culture to eliminate proliferating, nonneuronal
cells. To study polarity, neuronal morphology was analyzed at 3
DIV by immunostaining with neuronal-specific beta III tubulin
(TuJ1) (Covance) antibody. Neurons bearing only a single long
axon, indicative of normal neuronal polarization, were counted.
The neurons were stained with tau-1 antibody to confirm the
neuronal processes were axons.
For analysis of the enteric nervous system, E11.5 or E12.5 gut
was dissected from the mouse, fixed with 4% paraformaldehyde at
25uC for 30 min, and stained as a whole mount with TuJ1
antibody. The sympathetic nervous system was analyzed using
whole-mount TOH immunohistochemistry as described previous-
ly [22].
Analysis of lens development
The heads of E9.5 to E12.5 embryos were fixed in 4%
paraformaldehyde and embedded in paraffin with a specified
orientation for all specimens. Serial sections were stained with H &
E for microscopic examination. For BrdU immunostaining, timed
pregnant females were injected with 50 mg/kg body weight of a
mixture of 10 mM BrdU (Roche, Indianapolis, IN) and 1 mM 5-
fluoro-5-deoxyuridine (Sigma, St. Louis, MO) and sacrificed after
1 hour. Paraffin-embedded sections of embryonic head were
incubated with a monoclonal anti-BrdU antibody (1:250, Dako,
Carpinteria, CA) and visualized with a Vectastain Elite Mouse
IgG ABC kit (Dako, Carpinteria, CA).
Metaphase spread analysis of mouse embryonic
fibroblast cells
Chromosome analysis was performed in the cytogenetics core at
Washington University Medical School. Mouse embryonic
fibroblasts from wildtype, Pds5A, Pds5A
+/2;Pds5B
2/2, Pds5A
2/
2;Pds5B
+/2 or Pds5B mutant mice (passage 1–3) were cultured in
DMEM with 10% fetal bovine serum. Chromosomes were
harvested the day after plating after growth in colcemid (1 ug/
ml) for 1 h using standard hypotonic (0.075 M KCl) treatment and
fixation in methanol-acetic acid (3:1). Slides were prepared and
chromosomes were analyzed using the GTG (giemsa-banding
using trypsin and giemsa) banding method. More than two cell
lines were analyzed for each genotype. More than two cells were
fully analyzed from each line, and all were found to have normal
karyotypes. More than fifty cells were examined for precocious
sister chromatid separation (PSCS) for each line.
Fluorescence recovery after photobleaching (FRAP)
analysis of SCC1-EGFP
The SCC1 cDNA was released from pEGFP-N1-SCC1 (gift
from Cryns VL; [17]) by digestion with BglII and AgeI and inserted
into the BamHI and AgeI sites of FUGW (gift from Baltimore D;
[59]) to generate the SCC1-EGFP fusion construct in lentivirus
vector (named FU-SCC1-EGFP). Lentivirus expressing SCC1-
EGFP was made by standard methods with a titer of 10
6 to 10
7
infectious particles per mL. MEF cells were infected with lentivirus
for 12 hr followed by two washes with medium to remove
remaining virus. Three days after infection, MEF cells were
cultured on Lab-Tek Chambered CoverGlasses slides (Nunc) with
CO2-independent medium (Invitrogen) for FRAP. Half of the
nucleus was repeatedly bleached using a Leica SP5 confocal
microscope equipped with a 6061.4 oil immersion objective at
high laser power with a 6–86 zoom. The fluorescence intensity
was measured every 30 sec for 30 min post-bleaching with the
laser on low power. The difference in fluorescence between the
unbleached and bleached regions over time was calculated to
generate the re-equilibration curve. The fraction of weak vs. strong
chromatin bound SCC1-EGFP as well as their residence times
were calculated using bi-exponential function fitting as described
[35]. Unbound/soluble and chromatin-bound fractions were
determined by comparing the SCC1-EGFP fluorescences of
unbleached half nuclei before photobleaching and at t=0 s after
photobleaching, when nuclear-localized soluble EGFP that cannot
bind chromosomes gets completely bleached (Dorsett D, personal
communication). Re-equilibration curves incorporating data from
t=0 s after photobleaching and bi-exponential function fitting
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component, which has not been detected before [35]. MEFs
cannot be synchronized, so we were unable to detect the
differences in SCC1-chromatin association dynamics in G1 vs.
G2 cells in these FRAP assays.
Statistics
Data are expressed as mean6SD. Student’s t test was used for
comparisons between groups. P values of less than 0.05 were
considered significant.
Supporting Information
Supplementary Data and Materials S1
Found at: doi:10.1371/journal.pone.0005232.s001 (2.15 MB
PDF)
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